Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Principal investigator Dr. G. Scott Gazelle, director of MGH's Institute of Technology Assessment, and colleagues analyzed more than 526 million claims filed between 1999 and 2003. Investigators sought out the provider of the professional interpretation and organized data according to six conditions: cardiopulmonary disease, cardiovascular disease, extremity fracture, knee pain, intra-abdominal malignancy, and stroke. They then categorized each physician's proclivity to self-refer studies or refer them to radiologists (Radiology 2007 Nov;245[2]: 517-522).
Researchers found that self-referring physicians use imaging about twice as often as those who send their patients to radiologists. They also found that patient age and comorbidity do not explain the increased frequency for self-referred imaging.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.